logo
logo

Vizgen Secures $37M Series B Financing To Advance Spatial Genomics Through Commercialization Of Merscope™ Platform

Vizgen Secures $37M Series B Financing To Advance Spatial Genomics Through Commercialization Of Merscope™ Platform

04/07/21, 10:05 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcambridge
Money raised
$37 million
Round Type
series b
Vizgen, the life science company dedicated to advancing human health by visualizing single-cell spatial genomics information, has closed a $37 million Series B financing. The financing was co-led by Novalis LifeSciences LLC, and current investor Northpond Ventures. Also participating in the round were new investors Tao Capital Partners, Pura Vida Investments, LLC, and a large U.S. endowment fund

Company Info

Company
Vizgen
Location
cambridge, maryland, united states